Press Releases on December 4, 2023 - EIN Presswire - Press Release Distribution Service

Published on December 4, 2023 - 13:00 GMT

CHARGEPOINT INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies ChargePoint Investors of a Class Action Lawsuit and Upcoming ...

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc. (“ChargePoint” or the “Company”) (NYSE: …

Distribution channels: Law ...

Published on December 4, 2023 - 13:00 GMT

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal ...

SAN DIEGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced commencement of the Company’s pivotal Phase 3 clinical study of Ovaprene, an investigational hormone-free monthly …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma stärkt seine Führungsspitze mit der Ernennung von Jennifer Fox als Chief Business Officer und Chief Financial ...

WALTHAM, Massachusetts, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, ein weltweit tätiges Biopharmazieunternehmen, das sich der Aufgabe verschrieben hat, eine führende Position in der Entwicklung und Vermarktung von zielgerichteten Therapien für die …

Distribution channels:

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma fortalece el liderazgo ejecutivo con el nombramiento de Jennifer Fox como directora de negocios y directora ...

WALTHAM, MASSACHUSETTS, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, una empresa biofarmacéutica mundial comprometida a convertirse en líder en desarrollo y comercialización de terapias dirigidas de inflamación e inmunología (I&I), anunció hoy el …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial ...

WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, un laboratoire biopharmaceutique d’envergure mondiale déterminé à devenir un leader dans le développement et la commercialisation de traitements dans les domaines de l’inflammation …

Distribution channels:

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma מחזקת את ההנהלה הבכירה עם מינויין של ג'ניפר פוקס למנהלת עסקים ראשית ומנהלת כספים ראשית וד"ר טניה פישר, MD, PhD כראש...

וולטהאם, מסצ'וסטס, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, חברת ביופארמה גלובלית המחויבת להפוך למובילה בפיתוח ומסחור של טיפולים מבוססי מערכת החיסון – דלקת ואימונולוגיה (I&I), הודיעה היום על מינויין של ג'ניפר פוקס (Jennifer Fox …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma Memperkuat Jajaran Pemimpin dengan Mengangkat Jennifer Fox sebagai Chief Business Officer dan Chief Financial ...

WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, perusahaan biofarmasi global yang berkomitmen untuk menjadi pemimpin dalam pengembangan dan komersialisasi terapi terarah terkait inflamasi dan imunologi (I&I), hari ini mengumumkan …

Distribution channels:

Published on December 4, 2023 - 13:00 GMT

ゼナス・バイオファーマ (Zenas BioPharma)、最高事業責任者兼最高財務責任者にジェニファー・フォックス (Jennifer Fox)、研究開発責任者兼最高医学責任者にターニャ・フィッシャー医学博士 (Tanya Fischer, M.D., ...

マサチューセッツ州ウォルサム, Dec. 04, 2023 (GLOBE NEWSWIRE) -- 炎症および免疫領域 (I&I) 指向型治療薬の開発・商業化におけるリーダーとなることを目指すグローバルバイオ医薬品企業であるゼナス・バイオファーマ株式会社は本日、ジェニファー・フォックスを最高事業責任者兼最高財務責任者に、ターニャ・フィッシャー医学博士を研究開発責任者兼最高医学責任者に任命したと発表した。「 …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma, 사업부문 최고책임자 겸 재무부문 최고책임자에 Jennifer Foxㆍ 연구개발 책임자 겸 의료부문 최고책임자에 Tanya Fischer 박사 임명해 경영진 리더십 대폭 강화

월섬, 매사추세츠, Dec. 04, 2023 (GLOBE NEWSWIRE) -- 염증 및 면역체계 (I&I)에 기반한 치료법 개발과 상용화에 주력하는 글로벌 바이오 제약기업 Zenas BioPharma가 사업부문 최고책임자(CBO) 겸 재무부문 최고책임자(CFO) 자리엔 Jennifer Fox를, 연구개발(R&D) 책임자 겸 의료부문 최고책임자(CMO) 자리엔 Tanya Fischer를 임명한다고 오늘 발표했다. Zenas BioPharma …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya ...

WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se tornar líder no desenvolvimento e comercialização de terapias voltadas para inflamações e imunologia (I&I), divulgou hoje a …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma Memperkukuh Kepimpinan Eksekutif dengan Pelantikan Jennifer Fox sebagai Ketua Pegawai Perniagaan dan Ketua Pegawai ...

WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, sebuah syarikat biofarmaseutikal global yang komited untuk menjadi peneraju dalam pembangunan dan pengkomersialan terapi terarah keradangan dan imunologi (I&I), hari ini mengumumkan …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma เสริมสร้างความแข็งแกร่งของทีมผู้นำระดับผู้บริหารด้วยการแต่งตั้ง Jennifer Fox ดำรงตำแหน่งประธานเจ้าหน้าที่ฝ่ายธุรกิจ...

วอลแทม แมสซาชูเซต, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma บริษัทชีวเภสัชภัณฑ์ระดับโลกที่มุ่งมั่นที่จะเป็นผู้นำในการพัฒนาและทำธุรกิจด้านการรักษาการอักเสบและภูมิคุ้มกันวิทยา (I&I) ทางตรง ในวันนี้ได้ประกาศแต่งตั้ง Jennifer Fox ด …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma 任命 Jennifer Fox 为首席商务官兼首席财务官，任命 Tanya Fischer （医学士哲学博士双学位）为研发主管兼首席医学官，以加强行政领导层

马萨诸塞州沃尔瑟姆, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物制药公司，致力于成为炎症与免疫 (I&I) 定向疗法开发和商业化的领导者，今日宣布任命 Jennifer Fox 为首席商务官兼首席财务官，任命 Tanya Fischer（医学士哲学博士双学位）为研发主管兼首席医学官。 Zenas BioPharma 创始人兼首席执行官 Lonnie Moulder 表示：“我们很高兴欢迎 Tanya 和 Jen 加 …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Zenas BioPharma 任命 Jennifer Fox 為商務總監兼財務總監，任命 Tanya Fischer （醫學士哲學博士雙學位）為研發主管兼醫療總監，以加強行政領導層

馬薩諸塞州沃爾瑟姆, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物製藥公司，致力於成為炎症與免疫 (I&I) 定向療法開發和商業化的領導者，今日宣布任命 Jennifer Fox 為商務總監兼財務總監，任命 Tanya Fischer（醫學士哲學博士雙學位）為研發主管兼醫療總監。 Zenas BioPharma 創始人兼行政總裁 Lonnie Moulder 表示：「我們很高興歡迎 Tanya 和 Jen 加入我們的管理團隊。」「 …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

SL Green Announces Sale of 625 Madison Avenue

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG) Manhattan’s largest office landlord, today announced that, together with its partners, it has entered into a contract to sell the fee ownership interest in 625 Madison Avenue for …

Distribution channels: Business & Economy, Real Estate & Property Management ...

Published on December 4, 2023 - 13:00 GMT

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

BETHESDA, Md., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

IntelGenx Announces Changes to its Board of Directors

SAINT LAURENT, Quebec, Dec. 04, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces the resignation of Frank Stegert and Srinivas Rao from the Board of Directors of the Company (the “Board …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

ISC Selected by Bank of Canada to Operate New Bank Act Security Registry Under Five-Year Contract

REGINA, Saskatchewan, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) is pleased to announce that the Bank of Canada has selected the Company as operator and technology solutions provider for the Bank …

Distribution channels: Business & Economy ...

Published on December 4, 2023 - 13:00 GMT

Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical Data Being Presented at American ...

- Event to review initial clinical data from SUMMIT Part 1a in patients with Nonadvanced Systemic Mastocytosis (NonAdvSM) - Additional clinical data update from APEX Part 1 in patients with Advanced Systemic Mastocytosis (AdvSM) also to be reviewed WALTHAM …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 4, 2023 - 13:00 GMT

Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

SAN MATEO, Calif. and CAMBRIDGE, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that Jorge DiMartino M.D., Ph.D., chief medical officer …

Distribution channels: